BioForce Nanosciences Places Molecular Printing System with Russia s Institute of Biomedical Chemistry

Jan 30, 2006

NEW YORK, Jan. 30 (GenomeWeb News) - BioForce Nanosciences said today that it has placed the first international order for its NanoArrayer molecular printing system with the Institute of Biomedical Chemistry, a division of the Russian Academy of Medical Sciences in Moscow.

Terms of the deal were not disclosed.

Breaking News

In Brief This Week: The Jackson Laboratory, CareDx, Merck Global Health Innovation Fund, and More
People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More
New Products Posted to GenomeWeb: NanoString, Sophia Genetics, EliTech, Lybe Scientific, More
UK Government Suspends SARS-CoV-2 PCR Testing at Laboratory Due to Potential Erroneous Results
FDA Classifies Abbott SARS-CoV-2 Molecular Test Recall as Class I Due to False Positives
RADx Issues $77.7M in New Contracts for SARS-CoV-2 Rapid Diagnostic Tests

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more